NONINVASIVE IMPACT
Noninvasive colorectal cancer (CRC) screening options can lead to better outcomes1
The American Gastroenterological Association (AGA) supports CRC screening that includes both noninvasive screening options, like the Cologuard® test, and colonoscopy to improve participation in screening.2
~10 years
Estimated time it would take for gastroenterologists (GIs) to screen every eligible patient for CRC with colonoscopy only if noninvasive screening options were not offered.3-5*
Backlog of colonoscopies
The decrease in colonoscopy procedures caused by the national shortage of GIs, patient-perceived barriers to colonoscopy, as well as the pandemic, all contribute to prevent the screening gap from being closed.4,6,7
Noninvasive CRC screening may help1:
Rule out CRC in average-risk patients aged 45 and older.
Reserve time-consuming colonoscopy for high-risk patients and those with a positive result from a noninvasive test.
Cologuard performance
Learn how the Cologuard test can help you rule out CRC in your eligible patients.
Modeling data demonstrated that colonoscopies following positive stool-based tests have better outcomes compared to screening colonoscopy8
Colonoscopies following positive stool-based tests were associated with 3 times higher life-years gained compared with screening colonoscopy in a simulated study.8
Patient eligibility
Find out which of your patients are eligible for screening with the Cologuard test
- Years to screen each eligible patient calculated based on ~60 million patients at average risk due for CRC screening, ~14,000 actively practicing GIs in the US, and the estimated 426 colonoscopies performed by each GI annually.3-5